Treatment of Lymphadenitis
The treatment of lymphadenitis is determined by the causative organism: bacterial lymphadenitis requires antibiotic therapy targeting Staphylococcus aureus and Streptococcus pyogenes, while non-tuberculous mycobacterial (NTM) lymphadenitis demands complete surgical excision without chemotherapy as first-line treatment. 1, 2
Treatment Algorithm by Etiology
Acute Bacterial Lymphadenitis (Uncomplicated)
For early-stage bacterial lymphadenitis without abscess formation, initiate empiric oral antibiotics immediately: 2
- First-line options include clindamycin 300-450 mg orally three times daily OR amoxicillin-clavulanate 875/125 mg orally twice daily 2
- In low methicillin-resistant S. aureus (MRSA) prevalence settings, narrow-spectrum beta-lactam therapy such as flucloxacillin or first-generation cephalosporins is highly effective 3
- Continue antibiotics for 7-14 days for confirmed staphylococcal or streptococcal infections 2
- Obtain Gram stain and culture of aspirated material when possible to guide pathogen-specific therapy 2
Acute Bacterial Lymphadenitis (Complicated/Suppurative with Abscess)
When abscess formation is present, combine surgical drainage with antibiotic therapy: 2
- Hospitalize immunocompromised or neutropenic patients and initiate vancomycin plus antipseudomonal antibiotics 2
- Early imaging is essential to identify collections requiring drainage 3
- Prompt surgical intervention combined with infectious diseases consultation optimizes outcomes 3
- Treatment duration is typically longer than uncomplicated cases, with higher rates of clindamycin use in complicated disease 3
Non-Tuberculous Mycobacterial (NTM) Lymphadenitis
Complete excisional surgery without chemotherapy is the definitive treatment for NTM cervical lymphadenitis, achieving approximately 95% success rates: 1, 2
Critical Management Principles:
- Never perform incisional biopsy alone or simple drainage—this creates chronic fistulae, persistent disease, and sinus tract formation 1, 2
- Avoid anti-tuberculosis drugs without macrolides as they lead to treatment failure 1, 2
- For recurrent disease or when surgical risk is prohibitively high (particularly preauricular location with facial nerve injury risk), use a clarithromycin-based multidrug regimen 1, 2
- More aggressive management with both surgical excision and antibiotics is recommended for patients with overlying skin changes, multiple nodes, or bilateral disease, as these features predict de novo disease or recurrence 4
Tuberculous Lymphadenitis
When tuberculosis is suspected based on risk factors, initiate anti-tuberculosis therapy immediately while awaiting culture results: 1, 2
- Perform tuberculin skin test (PPD) in all suspected cases to distinguish tuberculous from non-tuberculous mycobacterial infection 2
- Discontinue anti-TB therapy if cultures fail to yield mycobacteria and no significant risk factors exist 2
- Treat tuberculous adenitis as a systemic disease with standard anti-tuberculosis medication regimens 5
Specific Pathogen-Directed Treatment
Cat Scratch Disease (Bartonella henselae)
- Azithromycin is the treatment of choice: 500 mg on day 1 followed by 250 mg daily for 4 additional days (for patients >45 kg), or 10 mg/kg on day 1 and 5 mg/kg daily for 4 more days (for patients <45 kg) 2
Tularemia
- Severe cases: streptomycin 15 mg/kg IM every 12 hours OR gentamicin 1.5 mg/kg IV every 8 hours 2
- Mild cases: tetracycline 500 mg orally four times daily OR doxycycline 100 mg orally twice daily 2
Bubonic Plague
- Streptomycin 15 mg/kg IM every 12 hours OR doxycycline 100 mg orally twice daily 2
- Gentamicin may substitute for streptomycin if unavailable 2
Borrelial Lymphocytoma (Lyme Disease)
Critical Pitfalls to Avoid
- Never perform incisional biopsy or drainage alone for suspected NTM lymphadenitis—this is the most common error leading to chronic complications 1, 2
- Do not use anti-TB drugs without macrolides for NTM infections 1, 2
- Always obtain cultures before starting antibiotics when feasible 2
- Recognize that preauricular location carries significant facial nerve injury risk during excision; consider medical therapy first in this anatomic location 2
- Failure to respond to empiric antibiotics within 48-72 hours should trigger diagnostic re-evaluation for alternative organisms or need for surgical intervention 6